• Improving
    Outcomes in
    Solid Tumor
    Cancer Treatment

    BIO300
    A New Class of Cancer Drug.
    Kills Cancer Cells.  Protects Normal Tissue.

  • Keeping America Safe

    BIO300
    Protecting Civilians, First Responders and Our Military
    from Nuclear Accidents and Terrorism.

Humanetics News

10.31.17

Humanetics Presents Data for Cancer Drug

Read More

10.10.17

Humanetics Receives New Grant from NASA

Read More

09.26.17

Humanetics Receives $3.8 Million Grant from Department of Defense

Read More

09.12.17

Humanetics Receives Patent for Cancer Drug

Read more

08.22.17

Humanetics to Present at Department of Defense Scientific Meeting

Read more

01.24.17

Humanetics Awarded Patent to Mitigate Erectile Dysfunction Associated with Prostate Cancer Radiotherapy

Read more

08.10.16

Humanetics Receives $597,000 Federal Grant to Continue Development of BIO 300 as a Medical Radiation Countermeasure

Read more

05.17.16

National Space Biology Research Institute to Fund Testing of BIO 300 to Protect Astronauts from Space Radiation
Read More